Literature DB >> 6711629

Responses of the growth-retarded fetus to acute hypoxemia.

B S Block, A J Llanos, R K Creasy.   

Abstract

Growth retardation in the human fetus associated with maternal cardiovascular disease is frequently accompanied by birth asphyxia and perinatal mortality. We have investigated the cardiovascular responses to acute hypoxemia in the fetal lamb with growth retardation secondary to embolization of the uteroplacental vascular bed. In the basal period, fetal arterial P02 and umbilical perfusion were significantly lower, and perfusion of the adrenal glands, brain, and heart was significantly higher, in embolized than in control fetal lambs. During imposed acute hypoxemia there was preferential perfusion of vital organs, the adrenal glands, brain, and heart in control and embolized fetuses. This preferential perfusion to the vital organs during hypoxemia was significantly more pronounced in embolized animals. Because of the increased compensation during acute hypoxemia, as reflected by the increased preferential perfusion of vital organs, the growth-retarded fetuses would probably decompensate sooner if the hypoxemia was prolonged.

Entities:  

Mesh:

Year:  1984        PMID: 6711629     DOI: 10.1016/0002-9378(84)90529-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  eNOS, NO, and the activation of ERK and AKT signaling at mid-gestation and near-term in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Thomas A Parker; Henry L Galan
Journal:  Syst Biol Reprod Med       Date:  2010-02       Impact factor: 3.061

2.  Does endothelin-1 reduce superior mesenteric artery blood flow velocity in preterm neonates?

Authors:  F J Weir; A Ohlsson; K Fong; K Amankwah; F Coceani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

3.  Effects of prevailing hypoxaemia, acidaemia or hypoglycaemia upon the cardiovascular, endocrine and metabolic responses to acute hypoxaemia in the ovine fetus.

Authors:  D S Gardner; A J W Fletcher; M R Bloomfield; A L Fowden; D A Giussani
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

4.  Adrenocortical responsiveness is blunted in twin relative to singleton ovine fetuses.

Authors:  D S Gardner; E Jamall; A J W Fletcher; A L Fowden; D A Giussani
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

5.  Evaluation of utero-placental and fetal hemodynamic parameters throughout gestation in pregnant mice using high-frequency ultrasound.

Authors:  Edgar Hernandez-Andrade; Hyunyoung Ahn; Gabor Szalai; Steven J Korzeniewski; Bing Wang; Mary King; Tinnakorn Chaiworapongsa; Nandor Gabor Than; Roberto Romero
Journal:  Ultrasound Med Biol       Date:  2013-12-15       Impact factor: 2.998

6.  Adrenergic and vasopressinergic contributions to the cardiovascular response to acute hypoxaemia in the llama fetus.

Authors:  D A Giussani; R A Riquelme; E M Sanhueza; M A Hanson; C E Blanco; A J Llanos
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

Review 7.  The fetal brain sparing response to hypoxia: physiological mechanisms.

Authors:  Dino A Giussani
Journal:  J Physiol       Date:  2016-01-06       Impact factor: 5.182

8.  Role of the α-adrenergic system in femoral vascular reactivity in neonatal llamas and sheep: a comparative study between highland and lowland species.

Authors:  Fernando A Moraga; Roberto V Reyes; Emilio A Herrera; Raquel A Riquelme; Germán Ebensperger; Víctor M Pulgar; Julian T Parer; Dino A Giussani; Aníbal J Llanos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-27       Impact factor: 3.619

9.  Fetal in vivo continuous cardiovascular function during chronic hypoxia.

Authors:  B J Allison; K L Brain; Y Niu; A D Kane; E A Herrera; A S Thakor; K J Botting; C M Cross; N Itani; K L Skeffington; C Beck; D A Giussani
Journal:  J Physiol       Date:  2016-03-01       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.